Novel biomarkers, including high-sensitivity troponins, growth differentiation factor-15 (GDF-15), and soluble suppression of tumorigenesis-2 (sST2), have emerged as potential early indicators of increased heart failure risk [10]. The gene discussed is GDF15; the disease is heart failure.